Your browser doesn't support javascript.
loading
Altered IgG glycosylation at COVID-19 diagnosis predicts disease severity.
Vicente, Manuel M; Alves, Inês; Gaifem, Joana; Rodrigues, Cláudia S; Fernandes, Ângela; Dias, Ana M; Stambuk, Jerko; Petrovic, Tea; Oliveira, Pedro; Ferreira-da-Silva, Frederico; Soares, Adriana; Seixas, Nair; Teixeira, Tiago; Malheiro, Luis; Abreu, Miguel M; Lauc, Gordan; Sarmento E Castro, Rui; Pinho, Salomé S.
Afiliación
  • Vicente MM; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
  • Alves I; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
  • Gaifem J; Graduate Program in Areas of Basic and Applied Biology (GABBA), ICBAS, University of Porto, Porto, Portugal.
  • Rodrigues CS; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal.
  • Fernandes Â; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
  • Dias AM; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal.
  • Stambuk J; Faculty of Medicine, University of Porto, Porto, Portugal.
  • Petrovic T; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
  • Oliveira P; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal.
  • Ferreira-da-Silva F; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
  • Soares A; Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Porto, Portugal.
  • Seixas N; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal.
  • Teixeira T; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
  • Malheiro L; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal.
  • Abreu MM; i3S - Institute for Research and Innovation in Health, University of Porto, Porto, Portugal.
  • Lauc G; Institute of Molecular Pathology and Immunology of University of Porto (IPATIMUP), Porto, Portugal.
  • Sarmento E Castro R; Genos Glycoscience Research Laboratory, Zagreb, Croatia.
  • Pinho SS; Genos Glycoscience Research Laboratory, Zagreb, Croatia.
Eur J Immunol ; 52(6): 946-957, 2022 06.
Article en En | MEDLINE | ID: mdl-35307819
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Portugal
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Portugal